Adaptive Biotechnologies Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Revenue	189.53	178.96	170.28	185.31	154.34	98.38	Upgrade
Revenue Growth (YoY)	8.61%	5.10%	-8.11%	20.06%	56.88%	15.65%	Upgrade
Cost of Revenue	88.09	89.16	96.02	75.6	191.64	138.6	Upgrade
Gross Profit	101.44	89.8	74.26	109.71	-37.3	-40.22	Upgrade
Selling, General & Admin	156.1	157.57	172.51	184.13	169.97	110.89	Upgrade
Research & Development	79.83	85.87	101.65	124.07	-	-	Upgrade
Operating Expenses	237.62	245.14	275.86	309.9	171.67	112.6	Upgrade
Operating Income	-136.19	-155.34	-201.61	-200.19	-208.97	-152.82	Upgrade
Interest Expense	-11.49	-11.58	-13.8	-4.24	-	-	Upgrade
Interest & Investment Income	6.47	6.33	6.35	4.8	8.9	7.36	Upgrade
EBT Excluding Unusual Items	-141.21	-160.6	-209.06	-199.63	-200.07	-145.45	Upgrade
Merger & Restructuring Charges	-7.21	-7.21	-	-	-	-	Upgrade
Gain (Loss) on Sale of Investments	6.52	8.21	9.18	-0.74	-7.23	-0.77	Upgrade
Asset Writedown	-	-	-25.43	-	-	-	Upgrade
Pretax Income	-141.89	-159.6	-225.3	-200.37	-207.3	-146.23	Upgrade
Earnings From Continuing Operations	-141.89	-159.6	-225.3	-200.37	-207.3	-146.23	Upgrade
Minority Interest in Earnings	0.06	0.1	0.05	0.18	0.02	-	Upgrade
Net Income	-141.84	-159.49	-225.25	-200.19	-207.28	-146.23	Upgrade
Net Income to Common	-141.84	-159.49	-225.25	-200.19	-207.28	-146.23	Upgrade
Shares Outstanding (Basic)	148	147	144	143	140	131	Upgrade
Shares Outstanding (Diluted)	148	147	144	143	140	131	Upgrade
Shares Change (YoY)	2.07%	1.88%	1.31%	1.54%	6.96%	89.71%	Upgrade
EPS (Basic)	-0.96	-1.08	-1.56	-1.40	-1.48	-1.11	Upgrade
EPS (Diluted)	-0.96	-1.08	-1.56	-1.40	-1.48	-1.11	Upgrade
Free Cash Flow	-88.76	-98.88	-167.02	-200.29	-254.47	-168.49	Upgrade
Free Cash Flow Per Share	-0.60	-0.67	-1.16	-1.41	-1.81	-1.28	Upgrade
Gross Margin	53.52%	50.18%	43.61%	59.20%	-24.17%	-40.88%	Upgrade
Operating Margin	-71.86%	-86.80%	-118.40%	-108.03%	-135.39%	-155.33%	Upgrade
Profit Margin	-74.84%	-89.12%	-132.28%	-108.03%	-134.30%	-148.63%	Upgrade
Free Cash Flow Margin	-46.83%	-55.25%	-98.09%	-108.09%	-164.87%	-171.26%	Upgrade
EBITDA	-117.41	-136.09	-179.38	-179.27	-195.01	-144.35	Upgrade
EBITDA Margin	-61.95%	-76.05%	-105.34%	-96.74%	-126.35%	-146.72%	Upgrade
D&A For EBITDA	18.77	19.26	22.23	20.92	13.95	8.47	Upgrade
EBIT	-136.19	-155.34	-201.61	-200.19	-208.97	-152.82	Upgrade
EBIT Margin	-71.86%	-86.80%	-118.40%	-108.03%	-135.39%	-155.33%	Upgrade
Advertising Expenses	-	6.1	8.6	13.7	-	14.5	Upgrade

Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q